[PDF][PDF] Dissemination and publication of research findings: an updated review of related biases
… F Song, S Parekh, L Hooper, YK Loke, J Ryder, AJ Sutton, C Hing, CS Kwok, C Pang,
and I Harvey … F Song,1,2* S Parekh,1,2 L Hooper,1 YK Loke,1 J Ryder,1 AJ Sutton,3 C …
and I Harvey … F Song,1,2* S Parekh,1,2 L Hooper,1 YK Loke,1 J Ryder,1 AJ Sutton,3 C …
Risk ofClostridium difficileInfection with acid suppressing drugs and antibiotics: Meta-analysis
…, S Singh, R Cavallazzi, YK Loke - Official journal of the …, 2012 - journals.lww.com
OBJECTIVES: Several studies have raised concern regarding the possible association
between proton-pump inhibitors (PPIs) andClostridium difficileinfection (CDI). We aimed to …
between proton-pump inhibitors (PPIs) andClostridium difficileinfection (CDI). We aimed to …
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta …
S Singh, YK Loke, CD Furberg - Jama, 2008 - jamanetwork.com
Context Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely used
in patients with chronic obstructive pulmonary disease (COPD) but their effect on the risk of …
in patients with chronic obstructive pulmonary disease (COPD) but their effect on the risk of …
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Non-randomised studies of the effects of interventions are critical to many areas of healthcare
evaluation, but their results may be biased. It is therefore important to understand and …
evaluation, but their results may be biased. It is therefore important to understand and …
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis
S Singh, YK Loke, CD Furberg - Jama, 2007 - jamanetwork.com
ContextRecent reports of serious adverse events with rosiglitazone use have raised
questions about whether the evidence of harm justifies its use for treatment of type 2 diabetes.…
questions about whether the evidence of harm justifies its use for treatment of type 2 diabetes.…
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
S Derry, YK Loke - Bmj, 2000 - bmj.com
Objectives: To assess the incidence of gastrointestinal haemorrhage associated with long
term aspirin therapy and to determine the effect of dose reduction and formulation on the …
term aspirin therapy and to determine the effect of dose reduction and formulation on the …
[HTML][HTML] Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
YK Loke, S Singh, CD Furberg - Cmaj, 2009 - Can Med Assoc
… Contributors: Yoon Loke and Sonal Singh conceptualized the … Yoon Loke will act as the
guarantor for the paper. All of the … Yoon Loke and Sonal Singh have no competing interests to …
guarantor for the paper. All of the … Yoon Loke and Sonal Singh have no competing interests to …
[PDF][PDF] What is the evidence of the impact of microfinance on the well-being of poor people?
Alternative formats If you require this document in an alternative format, please contact:
openaccess@bath.ac.uk Page 1 Citation for published version: Duvendack, M, Palmer-Jones, R, …
openaccess@bath.ac.uk Page 1 Citation for published version: Duvendack, M, Palmer-Jones, R, …
Does pharmacist‐led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta‐analysis
…, L Goodyer, S Hall, D Wright, YK Loke - British journal of …, 2008 - Wiley Online Library
We set out to determine the effects of pharmacist‐led medication review in older people by
means of a systematic review and meta‐analysis covering 11 electronic databases. …
means of a systematic review and meta‐analysis covering 11 electronic databases. …
PRISMA harms checklist: improving harms reporting in systematic reviews
L Zorzela, YK Loke, JP Ioannidis, S Golder… - bmj, 2016 - bmj.com
Introduction For any health intervention, accurate knowledge of both benefits and harms is
needed. Systematic reviews often compound poor reporting of harms in primary studies by …
needed. Systematic reviews often compound poor reporting of harms in primary studies by …